MariMed Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 148.6 million compared to USD 134.01 million a year ago. Net loss was USD 16.03 million compared to net income of USD 13.47 million a year ago.

Basic loss per share from continuing operations was USD 0.04 compared to basic earnings per share from continuing operations of USD 0.04 a year ago. Diluted loss per share from continuing operations was USD 0.04 compared to diluted earnings per share from continuing operations of USD 0.04 a year ago.